𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of type 2 diabetes with oral hypoglycaemics during ramadan

✍ Scribed by Sulimani, Riad A

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
125 KB
Volume
15
Category
Article
ISSN
1357-8170

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Multicentre study to assess quality of l
Multicentre study to assess quality of life and glycaemic control of Type 2 diabetic patients treated with insulin compared with oral hypoglycaemic agents
✍ Barnett, AH ;Jones, D Bowen ;Burden, AC ;Janes, JM ;Sinclair, A ;Small, M ;Tinda πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 530 KB

## Abstract Quality of life, glycaemic control and frequency of hypoglycaemia were compared in 93 moderate to poorly controlled Type 2 diabetes patients randomly allocated to one of three treatment groups: Group A continued on oral hypoglycaemics, Group B switched to twice‐daily fixed mixture of hu

Effects of the combination of insulin an
Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents
✍ S. Stenman; P. -H. Groop; C. Saloranta; K. J. TΓΆtterman; F. Fyhrqvist; L. Groop πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 971 KB

The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa

Effects of a combination of bedtime inte
Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents
✍ M. Krempf; T. Godeau; S. Ranganathan; P. Blanchard; P. Ritz; B. Charbonnel πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 603 KB

The effect of a subcutaneous injection of an intermediate-acting insulin at bedtime combined with glibenclamide has been evaluated in 16 non-insulin-diabetic patients with secondary failure to respond to oral agents. The patients showed poor metabolic control (HbA1 greater than 11%) after two months